ChiCTR2600124410 版本V1.0 版本创建时间2026/05/12 09:53:51 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600124410 

最近更新日期:

Date of Last Refreshed on:

2026-05-12 09:53:46 

注册时间:

Date of Registration:

2026-05-12 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

肌内效贴在脑卒中后肩手综合征患者中的应用分析

Public title:

Application Analysis of Kinesio Taping in Patients with Shoulder-Hand Syndrome after Stroke

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肌内效贴在脑卒中后肩手综合征患者中的应用分析

Scientific title:

Application Analysis of Kinesio Taping in Patients with Shoulder-Hand Syndrome after Stroke

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

雷玉楠 

研究负责人:

雷玉楠 

Applicant:

Yunan Lei 

Study leader:

Yunan Lei 

申请注册联系人电话:

Applicant telephone:

+86 151 0174 8296

研究负责人电话:

Study leader's
telephone:

+86 151 0174 8296

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

979961811@qq.com

研究负责人电子邮件:

Study leader's E-mail:

979961811@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国甘肃省酒泉市肃州区风电大道9号

研究负责人通讯地址:

中国甘肃省酒泉市肃州区风电大道9号

Applicant address:

No. 9, Fengdian Avenue, Suzhou District, Jiuquan, Gansu, China

Study leader's address:

No. 9, Fengdian Avenue, Suzhou District, Jiuquan, Gansu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市第一人民医院酒泉医院(酒泉市人民医院)

Applicant's institution:

Jiuquan Hospital of Shanghai First People's Hospital (Jiuquan People's Hospital)

研究负责人所在单位:

上海市第一人民医院酒泉医院(酒泉市人民医院)

Affiliation of the Leader:

Jiuquan Hospital of Shanghai First People's Hospital (Jiuquan People's Hospital)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

20260304009

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市第一人民医院酒泉医院(酒泉市人民医院)医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Jiuquan Hospital of Shanghai First People's Hospital (Jiuquan People's Hospital)

伦理委员会批准日期:

Date of approved by ethic committee:

2026-03-04 00:00:00

伦理委员会联系人:

张雅洁

Contact Name of the ethic committee:

Yajie Zhang

伦理委员会联系地址:

中国甘肃省酒泉市肃州区风电大道9号

Contact Address of the ethic committee:

No. 9, Fengdian Avenue, Suzhou District, Jiuquan, Gansu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 937 698 2243

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市第一人民医院酒泉医院(酒泉市人民医院)

Primary sponsor:

Jiuquan Hospital of Shanghai First People's Hospital (Jiuquan People's Hospital)

研究实施负责(组长)单位地址:

中国甘肃省酒泉市肃州区风电大道9号

Primary sponsor's address:

No. 9, Fengdian Avenue, Suzhou District, Jiuquan, Gansu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃

市(区县):

酒泉

Country:

China

Province:

Gansu

City:

Jiuquan

单位(医院):

上海市第一人民医院酒泉医院(酒泉市人民医院)

具体地址:

中国甘肃省酒泉市肃州区风电大道9号

Institution
hospital:

Jiuquan Hospital of Shanghai First People's Hospital (Jiuquan People's Hospital)

Address:

No. 9, Fengdian Avenue, Suzhou District, Jiuquan, Gansu, China

经费或物资来源:

自筹

Source(s) of funding:

Self-funded

研究疾病:

脑卒中后肩手综合征  

Target disease:

Shoulder-hand syndrome after stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

观察肌内效贴技术在脑卒中后肩手综合征患者肩部疼痛、肿胀及功能恢复中的疗效。比较肌内效贴技术与传统康复治疗方法在脑卒中后肩手综合征患者中的疗效差异。为肩手综合征患者的康复治疗提供更有效的治疗方案。  

Objectives of Study:

To observe the efficacy of kinesiology tape technique in shoulder pain, swelling and functional recovery in patients with shoulder-hand syndrome after stroke. To compare the efficacy differences between the intramuscular effect patch technique and traditional rehabilitation treatment methods in patients with shoulder-hand syndrome after stroke. Provide more effective treatment plans for the rehabilitation of patients with shoulder-hand syndrome.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.脑卒中(出血或缺血)后出现肩手综合征症状; 2.病程在脑卒中后 1-3 个月内; 3.年龄范围:年龄 18-80 岁; 4.知情同意:患者或法定监护人签署知情同意书,自愿参与研究; 5.能够配合完成相关评估和治疗;

Inclusion criteria

1. Shoulder-hand syndrome after stroke (hemorrhage or ischemia); 2. The course of disease within 1-3 months after stroke; 3. Age range: 18-80 years old; 4. Informed consent: patients or legal guardians signed informed consent to participate in the study voluntarily. 5. Be able to cooperate with the completion of relevant evaluation and treatment;

排除标准:

1.合并严重疾病:合并严重心、肝、肾功能不全;合并恶性肿瘤或其他严重系统性疾病;合并严重精神疾病或认知功能障碍(MMSE<20 分); 2.特殊人群:妊娠或哺乳期妇女;预期生存期小于 6 个月的患者; 3.既往病史:既往有肩关节周围疾病史(如肩周炎、肩袖损伤等);既往有同侧上肢骨折或手术史;既往有周围神经病变或臂丛神经损伤; 4.治疗因素:正在参加其他临床试验;对拟采用的治疗方法有禁忌证;已接受过针对肩手综合征的手术治疗; 5.依从性差:无法配合完成评估和治疗计划;预计随访困难或可能失访的患者; 6.其他因素:有药物或酒精滥用史;研究者认为不适合参与本研究的其他情况。

Exclusion criteria:

1.Combined severe diseases: Combined with severe heart, liver and kidney dysfunction; Combined with malignant tumors or other serious systemic diseases; Combined with severe mental illness or cognitive dysfunction (MMSE<20 points); 2. Special groups: Pregnant or lactating women; Patients with an expected survival period of less than 6 months; 3. Past medical history: There is a history of diseases around the shoulder joint (such as periarthritis of the shoulder, rotator cuff injury, etc.); There is a history of fractures or surgeries on the same side of the upper limb in the past. There was previous peripheral neuropathy or brachial plexus nerve injury; 4. Therapeutic factors: Currently participating in other clinical trials; There are contraindications to the proposed treatment method; Has received surgical treatment for shoulder-hand syndrome; 5. Poor compliance: Inability to cooperate in completing the assessment and treatment plan; 6. Other factors: History of drug or alcohol abuse; patients expected to have difficulty in follow-up or may be lost to follow-up. Other circumstances that the researchers consider unsuitable for participation in this study.

研究实施时间:

Study execute time:

From 2026-03-31 00:00:00 To 2027-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-05-31 00:00:00 To 2027-01-31 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

40

Group:

Control group

Sample size:

干预措施:

传统康复治疗(主/被动运动训练、针灸、超短波)

干预措施代码:

Intervention:

Traditional rehabilitation therapy (active/passive movement training, acupuncture and moxibustion, ultrashort wave therapy)

Intervention code:

组别:

试验组

样本量:

40

Group:

Experimental group

Sample size:

干预措施:

肌内效贴技术+传统康复治疗(主/被动运动训练、针灸、超短波)

干预措施代码:

Intervention:

Kinesio taping technique+Traditional rehabilitation therapy (active/passive movement training, acupuncture and moxibustion, ultrashort wave therapy)

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

甘肃 

市(区县):

酒泉 

Country:

China

Province:

Gansu

City:

Jiuquan

单位(医院):

上海市第一人民医院酒泉医院(酒泉市人民医院) 

单位级别:

三甲 

Institution
hospital:

Jiuquan Hospital of Shanghai First People's Hospital (Jiuquan People's Hospital)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肩部疼痛视觉模拟评分

指标类型:

主要指标

Outcome:

VAS for shoulder pain

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肩部活动度

指标类型:

主要指标

Outcome:

ROM of the shoulder

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Fugl-Meyer运动功能评定量表(上肢)

指标类型:

主要指标

Outcome:

Fugl-Meyer Assessment, FMA (Upper Limb)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手部肿胀程度

指标类型:

次要指标

Outcome:

The degree of hand swelling

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手部疼痛视觉模拟评分

指标类型:

次要指标

Outcome:

VAS for hand pain

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手部关节活动度

指标类型:

次要指标

Outcome:

ROM of hand joints

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

日常生活能力(Barthel指数)

指标类型:

次要指标

Outcome:

Activities of Daily Living, ADL(Barthel index)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用SPSS生成的随机数字表进行简单随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

It is planned to use the random number table generated by SPSS for simple random grouping

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

本研究对评估者实施盲法,鉴于治疗性质,无法对患者和治疗师设盲

Blinding:

Blinding is planned for the evaluators. Due to the nature of the treatment, blinding cannot be applied to the patients and therapists.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-05-12 09:53:46